BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2016
View Archived Issues
Special report: VHIO's Towards Predictive Cancer Models Symposium
Read More
Allergan discloses S1P1 ligands
Read More
New research alliance to discover novel treatments for severe fibrotic diseases
Read More
Biogen reports topline results from SYNERGY study
Read More
ALPK3 gene mutations identified in severe pediatric cardiomyopathy
Read More
Janssen begins first-in-human study of JNJ-63709178 for relapsed or refractory AML
Read More
Orphazyme cleared to begin AIDNPC intervention study of arimoclomol in U.S.
Read More
Tanaka Kikinzoku Kogyo develops kit to detect Zika virus in blood
Read More
Phase II dose selected for checkpoint inhibitor PDR-001 in first-in-human study
Read More
GlaxoSmithKline launches Nucala for bronchial asthma in Japan
Read More
Regulus Therapeutics announces phase II results on RG-101
Read More
Catabasis reports phase IIa topline data on CAT-2054 in hypercholesterolemia
Read More
FDA committee recommends approval of Teva's Vantrela ER
Read More
ABBV-399 shows promising antitumor activity for c-Met+ NSCLC
Read More
Skyepharma signs feasibility, development and license agreement with Lucideon
Read More
Pfizer announces phase II results of tofacitinib citrate
Read More
The role of RACK1 protein in development and progression of nasopharyngeal carcinoma
Read More
TapImmune exercises option agreement to Mayo Clinic HER2/neu vaccine technology
Read More
Novel xenograft models of digestive diseases
Read More
Sage Therapeutics reports promising phase I topline results for SAGE-217
Read More
Psilocybin shows promise in a feasibility trial as therapy for treatment-resistant depression
Read More
Sorrento and 3SBio form joint venture in China
Read More
Chiesi completes two pivotal studies of CHF-5993 for COPD
Read More
Axumin now available in U.S.
Read More
